Found: 141
Select item for more details and to access through your institution.
Decreased Incidence of Oncology Admissions in 75 Helios Hospitals in Germany during the COVID-19 Pandemic.
- Published in:
- Oncology Research & Treatment, 2021, v. 44, n. 3, p. 71, doi. 10.1159/000512935
- By:
- Publication type:
- Article
Treatment Modification in Young Breast Cancer Patients.
- Published in:
- Oncology Research & Treatment, 2016, v. 39, n. 3, p. 122, doi. 10.1159/000444355
- By:
- Publication type:
- Article
Intrinsic Subtypes of Primary Breast Cancer - Gene Expression Analysis.
- Published in:
- Oncology Research & Treatment, 2016, v. 39, n. 3, p. 102, doi. 10.1159/000444409
- By:
- Publication type:
- Article
Predictive Factors for Response to Neoadjuvant Therapy in Breast Cancer.
- Published in:
- Oncology Research & Treatment, 2014, v. 37, n. 10, p. 563, doi. 10.1159/000367643
- By:
- Publication type:
- Article
Management of Cytotoxic Extravasation - ASORS Expert Opinion for Diagnosis, Prevention and Treatment.
- Published in:
- Oncology Research & Treatment, 2013, v. 36, n. 3, p. 127, doi. 10.1159/000348524
- By:
- Publication type:
- Article
Variable number of tandem repeats polymorphism in the SMYD3 promoter region and the risk of familial breast cancer.
- Published in:
- International Journal of Cancer, 2006, v. 118, n. 11, p. 2917, doi. 10.1002/ijc.21696
- By:
- Publication type:
- Article
Association of the ARLTS1 Cys148Arg variant with familial breast cancer risk.
- Published in:
- International Journal of Cancer, 2006, v. 118, n. 10, p. 2505, doi. 10.1002/ijc.21687
- By:
- Publication type:
- Article
Limited relevance of the CHEK2 gene in hereditary breast cancer.
- Published in:
- International Journal of Cancer, 2004, v. 110, n. 3, p. 320, doi. 10.1002/ijc.20073
- By:
- Publication type:
- Article
Nucleosomes in serum of patients with benign and malignant diseases.
- Published in:
- International Journal of Cancer, 2001, v. 95, n. 2, p. 114, doi. 10.1002/1097-0215(20010320)95:2<114::AID-IJC1020>3.0.CO;2-Q
- By:
- Publication type:
- Article
Photodynamic therapy of vulvar intraepithelial neoplasia using 5-aminolevulinic acid.
- Published in:
- International Journal of Cancer, 2000, v. 85, n. 5, p. 649, doi. 10.1002/(SICI)1097-0215(20000301)85:5<649::AID-IJC9>3.0.CO;2-E
- By:
- Publication type:
- Article
Photodynamic therapy in women with cervical intraepithelial neoplasia using topically applied 5-aminolevulinic acid.
- Published in:
- International Journal of Cancer, 1999, v. 81, n. 1, p. 34, doi. 10.1002/(SICI)1097-0215(19990331)81:1<34::AID-IJC7>3.0.CO;2-H
- By:
- Publication type:
- Article
Pharmacokinetics and selectivity of aminolevulinic acid-induced porphyrin synthesis in patients with cervical intra-epithelial neoplasia.
- Published in:
- International Journal of Cancer, 1998, v. 78, n. 3, p. 310, doi. 10.1002/(SICI)1097-0215(19981029)78:3<310::AID-IJC9>3.0.CO;2-Y
- By:
- Publication type:
- Article
Th2/Th17 cell associated cytokines found in seroma fluids after breast cancer surgery.
- Published in:
- Archives of Gynecology & Obstetrics, 2023, v. 308, n. 5, p. 1621, doi. 10.1007/s00404-023-07074-w
- By:
- Publication type:
- Article
Current trends in diagnostic and therapeutic management of the axilla in breast cancer patients receiving neoadjuvant therapy: results of the German-wide NOGGO MONITOR 24 survey.
- Published in:
- Archives of Gynecology & Obstetrics, 2023, v. 307, n. 5, p. 1547, doi. 10.1007/s00404-022-06804-w
- By:
- Publication type:
- Article
How to Optimise Extended Adjuvant Treatment with Neratinib for Patients with Early HER2+ Breast Cancer.
- Published in:
- Oncology & Therapy, 2021, v. 9, n. 2, p. 297, doi. 10.1007/s40487-021-00153-5
- By:
- Publication type:
- Article
Pattern of S100-release in benign and malignant diseases beside malignant melanoma/Freisetzung von S100 bei benignen und malignen Erkrankungen jenseits des malignen Melanoms.
- Published in:
- 2013
- By:
- Publication type:
- Journal Article
CEA und CA15-3 beim fortgeschrittenen Mammakarzinom.
- Published in:
- Journal of Laboratory Medicine / Laboratoriums Medizin, 2007, v. 31, n. 2, p. 70, doi. 10.1515/JLM.2007.014
- By:
- Publication type:
- Article
Association of the CASP10 V410I variant with reduced familial breast cancer risk and interaction with the CASP8 D302H variant.
- Published in:
- Carcinogenesis, 2006, v. 27, n. 3, p. 606, doi. 10.1093/carcin/bgi248
- By:
- Publication type:
- Article
Association of death receptor 4 haplotype 626C–683C with an increased breast cancer risk.
- Published in:
- Carcinogenesis, 2005, v. 26, n. 11, p. 1975, doi. 10.1093/carcin/bgi164
- By:
- Publication type:
- Article
Early Modulation of Circulating MicroRNAs Levels in HER2-Positive Breast Cancer Patients Treated with Trastuzumab-Based Neoadjuvant Therapy.
- Published in:
- International Journal of Molecular Sciences, 2020, v. 21, n. 4, p. 1386, doi. 10.3390/ijms21041386
- By:
- Publication type:
- Article
Adding epoetin alfa to intense dose-dense adjuvant chemotherapy for breast cancer: randomized clinical trial.
- Published in:
- 2013
- By:
- Publication type:
- journal article
Adding Epoetin Alfa to Intense Dose-Dense Adjuvant Chemotherapy for Breast Cancer: Randomized Clinical Trial.
- Published in:
- JNCI: Journal of the National Cancer Institute, 2013, v. 105, n. 14, p. 1018
- By:
- Publication type:
- Article
HER-2/neu Gene Amplification and Response to Paclitaxel in Patients With Metastatic Breast Cancer.
- Published in:
- JNCI: Journal of the National Cancer Institute, 2004, v. 96, n. 15, p. 1141, doi. 10.1093/jnci/djh198
- By:
- Publication type:
- Article
Quantitative association between HER-2/neu and steroid hormone receptors in hormone receptor-positive primary breast cancer.
- Published in:
- 2003
- By:
- Publication type:
- journal article
Comparative analyses of bone marrow micrometastases in breast and gastric cancer.
- Published in:
- International Journal of Cancer, 1996, v. 65, n. 6, p. 755, doi. 10.1002/(SICI)1097-0215(19960315)65:6<755::AID-IJC8>3.0.CO;2-Y
- By:
- Publication type:
- Article
Effect of Tailored Dose-Dense Chemotherapy vs Standard 3-Weekly Adjuvant Chemotherapy on Recurrence-Free Survival Among Women With High-Risk Early Breast Cancer: A Randomized Clinical Trial.
- Published in:
- 2016
- By:
- Publication type:
- journal article
Rationale and trial design of NATALEE: a Phase III trial of adjuvant ribociclib + endocrine therapy versus endocrine therapy alone in patients with HR+/HER2− early breast cancer.
- Published in:
- Therapeutic Advances in Medical Oncology, 2023, v. 15, p. 1, doi. 10.1177/17588359231178125
- By:
- Publication type:
- Article
Post-Mastectomy Radiotherapy After Neoadjuvant Chemotherapy in Breast Cancer: A Pooled Retrospective Analysis of Three Prospective Randomized Trials.
- Published in:
- Annals of Surgical Oncology: An Oncology Journal for Surgeons, 2019, v. 26, n. 12, p. 3892, doi. 10.1245/s10434-019-07635-x
- By:
- Publication type:
- Article
Outcomes of patients with small and node-negative HER2-positive early breast cancer treated with adjuvant chemotherapy and anti-HER2 therapy-a sub-analysis of the ALTTO study.
- Published in:
- 2022
- By:
- Publication type:
- journal article
Return of individual genomic research results within the PRAEGNANT multicenter registry study.
- Published in:
- Breast Cancer Research & Treatment, 2023, v. 197, n. 2, p. 355, doi. 10.1007/s10549-022-06795-x
- By:
- Publication type:
- Article
The effect of participation in neoadjuvant clinical trials on outcomes in patients with early breast cancer.
- Published in:
- Breast Cancer Research & Treatment, 2018, v. 171, n. 3, p. 747, doi. 10.1007/s10549-018-4829-4
- By:
- Publication type:
- Article
Outcome after neoadjuvant chemotherapy in estrogen receptor-positive and progesterone receptor-negative breast cancer patients: a pooled analysis of individual patient data from ten prospectively randomized controlled neoadjuvant trials.
- Published in:
- Breast Cancer Research & Treatment, 2018, v. 167, n. 1, p. 59, doi. 10.1007/s10549-017-4480-5
- By:
- Publication type:
- Article
Efficacy and safety of nab-paclitaxel 125 mg/m and nab-paclitaxel 150 mg/m compared to paclitaxel in early high-risk breast cancer. Results from the neoadjuvant randomized GeparSepto study (GBG 69).
- Published in:
- Breast Cancer Research & Treatment, 2017, v. 163, n. 3, p. 495, doi. 10.1007/s10549-017-4200-1
- By:
- Publication type:
- Article
A randomized phase III study evaluating pegylated liposomal doxorubicin versus capecitabine as first-line therapy for metastatic breast cancer: results of the PELICAN study.
- Published in:
- Breast Cancer Research & Treatment, 2017, v. 161, n. 1, p. 63, doi. 10.1007/s10549-016-4033-3
- By:
- Publication type:
- Article
Trastuzumab re-treatment following adjuvant trastuzumab and the importance of distant disease-free interval: the HERA trial experience.
- Published in:
- Breast Cancer Research & Treatment, 2016, v. 155, n. 1, p. 127, doi. 10.1007/s10549-015-3656-0
- By:
- Publication type:
- Article
Outcome after neoadjuvant chemotherapy in young breast cancer patients: a pooled analysis of individual patient data from eight prospectively randomized controlled trials.
- Published in:
- Breast Cancer Research & Treatment, 2015, v. 152, n. 2, p. 377, doi. 10.1007/s10549-015-3479-z
- By:
- Publication type:
- Article
Impact of body mass index on neoadjuvant treatment outcome: a pooled analysis of eight prospective neoadjuvant breast cancer trials.
- Published in:
- Breast Cancer Research & Treatment, 2015, v. 150, n. 1, p. 127, doi. 10.1007/s10549-015-3287-5
- By:
- Publication type:
- Article
Changes in serum levels of miR-21, miR-210, and miR-373 in HER2-positive breast cancer patients undergoing neoadjuvant therapy: a translational research project within the Geparquinto trial.
- Published in:
- Breast Cancer Research & Treatment, 2014, v. 147, n. 1, p. 61, doi. 10.1007/s10549-014-3079-3
- By:
- Publication type:
- Article
Central pathology laboratory review of HER2 and ER in early breast cancer: an ALTTO trial [BIG 2-06/NCCTG N063D (Alliance)] ring study.
- Published in:
- Breast Cancer Research & Treatment, 2014, v. 143, n. 3, p. 485, doi. 10.1007/s10549-013-2827-0
- By:
- Publication type:
- Article
Adjuvant Anti-HER2 Therapy, Treatment-Related Amenorrhea, and Survival in Premenopausal HER2-Positive Early Breast Cancer Patients.
- Published in:
- 2019
- By:
- Publication type:
- journal article
Lapatinib-Related Rash and Breast Cancer Outcome in the ALTTO Phase III Randomized Trial.
- Published in:
- 2016
- By:
- Publication type:
- journal article
Response.
- Published in:
- 2014
- By:
- Publication type:
- Journal Article
Baseline CD4<sup>+</sup> and expansion of γδ T cells correlate with response to durvalumab in triple‐negative breast cancer patients.
- Published in:
- Clinical & Translational Medicine, 2024, v. 14, n. 4, p. 1, doi. 10.1002/ctm2.1617
- By:
- Publication type:
- Article
Development of central nervous system metastases as a first site of metastatic disease in breast cancer patients treated in the neoadjuvant trials GeparQuinto and GeparSixto.
- Published in:
- 2019
- By:
- Publication type:
- journal article
Fatal events during clinical trials: an evaluation of deaths during breast cancer studies.
- Published in:
- Breast Cancer (13406868), 2019, v. 26, n. 6, p. 826, doi. 10.1007/s12282-019-00990-3
- By:
- Publication type:
- Article
Neoadjuvant Clinical Trials for the Treatment of Primary Breast Cancer: The Experience of the German Study Groups.
- Published in:
- Current Oncology Reports, 2012, v. 14, n. 1, p. 27, doi. 10.1007/s11912-011-0212-x
- By:
- Publication type:
- Article
Heregulin (HRG) assessment for clinical trial eligibility testing in a molecular registry (PRAEGNANT) in Germany.
- Published in:
- 2020
- By:
- Publication type:
- journal article
Zielgerichtete intraoperative Strahlentherapie als vorgezogener Boost im Rahmen der brusterhaltenden Operation nach neoadjuvanter Chemotherapie.
- Published in:
- 2017
- By:
- Publication type:
- journal article
Analysis of Regional Timelines To Set Up a Global Phase III Clinical Trial in Breast Cancer: The Adjuvant Lapatinib and/or Trastuzumab Treatment Optimization Experience.
- Published in:
- Oncologist, 2013, v. 18, n. 2, p. 134, doi. 10.1634/theoncologist.2012-0342
- By:
- Publication type:
- Article
Neutropenic complications in the PANTHER phase III study of adjuvant tailored dose-dense chemotherapy in early breast cancer.
- Published in:
- Acta Oncologica, 2020, v. 59, n. 1, p. 75, doi. 10.1080/0284186X.2019.1670353
- By:
- Publication type:
- Article